PCRX (NASDAQ: PCRX) insider sale notice lists 3 share lots

Rhea-AI Filing Summary

PCRX files a Form 144 reporting proposed sale of Common Stock. The filing lists prior acquisitions of Common Stock: 209 shares purchased under an ESPP on 12/31/2021, 2,000 shares acquired on exercise of stock options on 05/23/2022, and 1,052 shares from restricted stock vesting on 06/03/2022. The notice identifies Fidelity Brokerage Services LLC as the broker.

Insights

Securities Counsel

Form 144 notifies the SEC and broker of an affiliate's intent to sell registered securities.

Form 144 is a regulatory notice required when affiliates propose to sell restricted or control securities in reliance on certain exemptions. The filing here lists acquisition dates and lot sizes: 209, 2,000, and 1,052 shares with corresponding dates.

Cash‑flow treatment and proposed sale timing are not stated in the excerpt; subsequent trade execution and sale methods will be reflected in later broker records or resale filings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3261	74416.02	40489894	03/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2021	ESPP Purchase	Issuer			209	12/31/2021	Cash
Common	05/23/2022	Stock Option Exercise	Issuer			2000	05/23/2022	Cash
Common	06/03/2022	Restricted Stock Vesting	Issuer			1052	06/03/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PCRX's Form 144 mean for shareholders?

Form 144 notifies regulators and broker-dealers of an affiliate's intent to sell shares. The filing lists acquired lots of 209, 2,000, and 1,052 shares with acquisition dates, but does not report completed trades.

Who is the broker listed on the PCRX Form 144?

The filing names Fidelity Brokerage Services LLC at the Smithfield, RI address as the broker. Broker identification in Form 144 allows market participants to track any subsequent resale transactions.

Which lots of PCRX common stock are listed on the Form 144?

The notice lists three acquisition events: an ESPP purchase of 209 shares on 12/31/2021, a stock option exercise of 2,000 shares on 05/23/2022, and restricted stock vesting of 1,052 shares on 06/03/2022.

Does the Form 144 mean the shares have been sold?

No. Form 144 indicates an intention or notice to sell by an affiliate; it does not confirm completed sales. Trade execution details would appear in subsequent broker records or resale filings if sales occur.